Mitochondrial-targeted lipid nanoparticles are a breakthrough in delivering therapeutic agents directly to mitochondria, the powerhouse of cells. These nanoparticles are designed to address mitochondrial dysfunction, a key factor in diseases like neurodegenerative disorders, metabolic syndromes, and cancer.